Chemotherapeutic agents fail in clinical chemotherapy
in the absence
of targeting and acquired resistance. We, therefore, synthesized Fe3O4@ZIF-8@Sor@TA nanocomposite drugs based on the
drug delivery properties of nanomaterials. ZIF-8 is a nanomaterial
with a porous structure that can load anticancer drugs. The nanodrug
used the paramagnetic property of Fe3O4 to deliver
sorafenib (Sor) precisely to the tumor site, then used the pH responsiveness
of ZIF-8 to slowly release Sor in the tumor microenvironment, and
finally used tannic acid (TA) to inhibit P-glycoprotein to suppress
the Sor resistance. The results of material characterization presented
that the prepared material was structurally stable and was able to
achieve a cumulative drug release of 38.2% at pH 5.0 for 72 h. The
good biocompatibility of the composite was demonstrated by in vitro
and in vivo experiments, which could improve antitumor activity and
reduce Sor resistance through magnetic targeting TA. In conclusion,
the Fe3O4@ZIF-8@Sor@TA material prepared in
this study demonstrated high antitumor activity in hepatocellular
carcinoma treatment, promising to reduce drug resistance and providing
a novel research approach for cancer treatment.